Insights for your outreach

Department Breakdown

Top Genetics Companies

Name: Top Genetics Companies
Creator: Surfe
Published: 2025-09-25 16:56:43
License: https://creativecommons.org/licenses/by-nc/4.0/

Last updated:25 Sep 2025

Created by Surfe | Views: 23

Market context behind this list

Sort by

Companies

Key Contacts

Annual Revenue

Funding

Company Growth

Team Growth

Hiring Status

Clear all

Annual Revenue

0-1M

1-10M

10-50M

50-100M

100-500M

500-1,000M

>1,000M

Clear all

Company Growth

1-20%

20-50%

50-100%

100%+

Clear all

Team Growth

1-20%

20-50%

50-100%

100%+

Clear all

Location

New Delhi, India

Irving, Texas, United States

Eugene, Oregon, United States

Somerville, Massachusetts, United States

Saffron Walden, United Kingdom

Kampenhout, Belgium

Madrid, Spain

Gaithersburg, Maryland, United States

Coralville, Iowa, United States

Jamestown, New York, United States

Coral Springs, Florida, United States

Geneva, Switzerland

Levallois-Perret, France

Bar Harbor, Maine, United States

Norwich, United Kingdom

Melbourne, Australia

Gurgaon, India

Menlo Park, California, United States

San Francisco, California, United States

South Brunswick, New Jersey, United States

Darlinghurst, Australia

Manchester, United Kingdom

Aliso Viejo, California, United States

Boxmeer, Netherlands

Saint-Ouen-sur-Seine, France

Modena, Italy

Kerhonkson, New York, United States

Montvale, Virginia, United States

Farmingdale, New York, United States

Atlanta, Georgia, United States

Seattle, Washington, United States

Rockville, Maryland, United States

Noyal-sur-Vilaine, France

Chennai, India

San Jose, California, United States

Woodbridge Township, New Jersey, United States

Rolle, Switzerland

Port Chester, United States

Hoddesdon, United Kingdom

Thorold, Canada

London, United Kingdom

Montreal, Canada

Bothell, Washington, United States

Glen Allen, Virginia, United States

Lexington, Kentucky, United States

South Cambridgeshire, United Kingdom

Yuexiu District, China

Fargo, North Dakota, United States

Louverné, France

Gurugram, India

Amsterdam, Netherlands

Vancouver, Canada

Sydney, Australia

Boston, Massachusetts, United States

New York, United States

Solna, Sweden

Cambridge, Massachusetts, United States

New York, New York, United States

Cambridge, United States

Chicago, Illinois, United States

Rochester, Minnesota, United States

Fort Myers, Florida, United States

Novato, California, United States

Badalona, Spain

Shanghai, China

Danderyd, Sweden

City of New Rochelle, New York, United States

Waltham, Massachusetts, United States

Ougrée, Belgium

Secaucus, United States

Bengaluru, India

Toronto, Canada

Bergisch Gladbach, Germany

Braunschweig, Germany

Minneapolis, Minnesota, United States

Salt Lake City, Utah, United States

Nußloch, Germany

Palm Harbor, Florida, United States

Mainz, Germany

Framingham, Massachusetts, United States

Strasbourg, France

Rome, Italy

Fremont, California, United States

Limburg, Germany

Abingdon, United Kingdom

Munich, Germany

DeForest, Wisconsin, United States

Pune, India

Newstead, New Zealand

Clear all

	Companies		Key Contacts		Annual Revenue	Funding	Company Growth	Management Team Growth	Hiring Status	Tech Stack	HQ Location
1	Australian Clinical Labs Biotechnology	741	Pathologist, Phlebotomist, Data Entry Executives	>100	$500-1,000M		📉 Negative Growth: -0.4% 744 ↘ 741 Employees	📈 Strong growth: 30% 10 ↗ 13 Employees	Not Hiring	11	Melbourne, Australia
2	Ambry Genetics Biotechnology	623	Technical Support Supervisor, Clinical Product Specialist, Director of Business Development	>100	$100-500M		📊 Modest Growth: 5.06% 593 ↗ 623 Employees	📊 Modest Growth: 12.5% 8 ↗ 9 Employees	Actively Hiring	15	Aliso Viejo, California, United States
3	Sarepta Therapeutics Biotechnology	1,170	Director, Gene Therapy Global Medical Affairs Lead (GMAL), Vice President, Litigation, Associate Director, Payer Marketing/Market Access Marketing	>100	$100-500M	$5M raised Post-IPO Equity, 09-14-2022	📊 Modest Growth: 6.36% 1,100 ↗ 1,170 Employees	📊 Modest Growth: 9.52% 21 ↗ 23 Employees	Actively Hiring	27	Cambridge, Massachusetts, United States
4	Regenxbio Biotechnology	286	Project Manager, Clinical Delivery, Summer Internship: Vector Core - Upstream Operations, Senior Regulatory Operations Associate	>100	$100-500M	$140M raised Post-IPO Equity, 03-06-2024	📊 Modest Growth: 4% 275 ↗ 286 Employees	📊 Modest Growth: 9.09% 11 ↗ 12 Employees	Actively Hiring	25	Rockville, Maryland, United States
5	Repligen Biotechnology	848	Associate Director, New Product Introduction Project Manager, Quality Assurance Associate 1	>100	$100-500M	$600M raised Post-IPO Debt, 12-06-2023	📊 Modest Growth: 2.54% 827 ↗ 848 Employees	📊 Modest Growth: 3.85% 26 ↗ 27 Employees	Actively Hiring	39	Waltham, Massachusetts, United States
6	Ceva Santé Animale Health Care	3,686	Controlled-Temperature Manager, Territory Manager, Hatchery Vaccination Service Manager	>100	$500-1,000M		📊 Modest Growth: 0.49% 3,668 ↗ 3,686 Employees	📊 Modest Growth: 1.3% 77 ↗ 78 Employees	Actively Hiring	22	Louverné, France
7	Moderna Biotechnology	5,215	GMP Manufacturing Compliance Specialist, Sr. Manager, Delivery Science, QA Specialist	>100	$100-500M	$590M raised Grant, 01-17-2025	📉 Negative Growth: -1.12% 5,274 ↘ 5,215 Employees	📊 Modest Growth: 1.19% 84 ↗ 85 Employees	Actively Hiring	24	Cambridge, Massachusetts, United States
8	Sgs Nutrition	28,095	Business Development Manager, Mergers and Acquisitions, Analista de laboratorio, Associate	>100	$500-1,000M		📉 Negative Growth: -0.54% 28,248 ↘ 28,095 Employees	📊 Modest Growth: 0.16% 638 ↗ 639 Employees	Actively Hiring	27	Geneva, Switzerland
9	The Rockefeller University Biotechnology	1,016	Other, Accounts Payable Administrator, research associate	>100	$500-1,000M	$2M raised Grant, 01-01-2020	📉 Negative Growth: -0.49% 1,021 ↘ 1,016 Employees	⏸️ No Growth: 0% 5 Employees	Not Hiring	32	New York, New York, United States
10	Bio-Techne Biotechnology	1,408	Senior Controls Engineer, International Customer Care Representative at Bio-Techne, Product Marketing Specialist	>100	$500-1,000M		📉 Negative Growth: -0.28% 1,412 ↘ 1,408 Employees	⏸️ No Growth: 0% 16 Employees	Actively Hiring	17	Minneapolis, Minnesota, United States
11	Diagenode Bioinformatics	108	Quality Engineer, Laboratory Technician, Technicien de maintenance et production	>100	$100-500M	$8M raised Venture Round, 06-20-2016	📉 Negative Growth: -1.82% 110 ↘ 108 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	36	Ougrée, Belgium
12	Biogroup Biotechnology	1,061	Technicienne en laboratoire, Infirmier, Gestionnaire de stock	>100	$500-1,000M	$3,030M raised Debt Financing, 02-12-2021	📉 Negative Growth: -1.12% 1,073 ↘ 1,061 Employees	⏸️ No Growth: 0% 16 Employees	Actively Hiring	27	Levallois-Perret, France
13	Broad Institute Biotechnology	2,568	Graduate Research Assistant in David Liu's lab, Clinical Genomics Coordinator, Research Affiliate	>100	$500-1,000M		📉 Negative Growth: -0.77% 2,588 ↘ 2,568 Employees	⏸️ No Growth: 0% 13 Employees	Actively Hiring	12	Cambridge, United States
14	Hendrix Genetics Genetics	388	Recursos humanos, Global Director of Research, Development and Innovaiton, Responsable production	>100	$100-500M		📊 Modest Growth: 0.52% 386 ↗ 388 Employees	⏸️ No Growth: 0% 8 Employees	Actively Hiring	9	Boxmeer, Netherlands
15	Norgen Biotek Biotechnology	39	Account Executive, Full Stack Developer, Marketing Associate (Graphic Designer)	+59	$100-500M		📉 Negative Growth: -4.88% 41 ↘ 39 Employees	⏸️ No Growth: 0% 1 Employees	Actively Hiring	24	Thorold, Canada
16	Genes2me LLC Biotechnology	55	Geneticist, Junior scientific officer, Assistant Manager OPC	+69	$100-500M		📉 Negative Growth: -1.79% 56 ↘ 55 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	39	Gurgaon, India
17	Evolution Genetics	48	Inséminateur, Responsable agence, Marketing Manager	+77	$100-500M		📉 Negative Growth: -2.04% 49 ↘ 48 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	9	Noyal-sur-Vilaine, France
18	Quest Diagnostics Health Care	13,048	Scientist Certifying-Positive, Courier, PS Supervisor	>100	$>1,000M	$1,850M raised Post-IPO Debt, 08-15-2024	📉 Negative Growth: -0.1% 13,061 ↘ 13,048 Employees	⏸️ No Growth: 0% 90 Employees	Actively Hiring	20	Secaucus, United States
19	Max Planck Society Biotechnology	294	Doctoral Student, Wissenschaftlicher Mitarbeiter (Postdoktorand), Doctoral Candidate	>100	$100-500M		📊 Modest Growth: 0.34% 293 ↗ 294 Employees	⏸️ No Growth: 0% 7 Employees	Not Hiring	11	Munich, Germany
20	DNA Painter Genetics		Founder	+1	$100-500M		⏸️ No Growth: 0% Employees	⏸️ No Growth: 0% Employees	Not Hiring	22	London, United Kingdom
21	Tempus Biotechnology	1,983	Senior Scientist, Data Solutions, Lead Clinical Laboratory Associate III - Returns, Molecular Technologist	>100	$100-500M		📊 Modest Growth: 5.93% 1,872 ↗ 1,983 Employees	⏸️ No Growth: 0% 41 Employees	Actively Hiring	21	Chicago, Illinois, United States
22	ARUP Laboratories Clinical Trials	1,744	Medical Technologist, Client Relations Specialist, Software Developer	>100	$100-500M	$3M raised Grant, 01-10-2023	📊 Modest Growth: 0.87% 1,729 ↗ 1,744 Employees	⏸️ No Growth: 0% 8 Employees	Actively Hiring	18	Salt Lake City, Utah, United States
23	The Jackson Laboratory Biotechnology	1,493	Human Resources Business Partner, Supervisor of security, Supervisor	>100	$100-500M	$1M raised Grant, 10-07-2024	📉 Negative Growth: -0.4% 1,499 ↘ 1,493 Employees	⏸️ No Growth: 0% 18 Employees	Actively Hiring	19	Bar Harbor, Maine, United States
24	Talis Biomedical Biotechnology	42	Senior Principal Hardware Manufacturing Test Engineer, Senior Reagent Manufacturing & QC Associate, Assay Development, Senior Vice President Corporate and Business Development	+26	$500-1,000M	$8M raised Grant, 05-10-2018	📉 Negative Growth: -2.33% 43 ↘ 42 Employees	⏸️ No Growth: 0% 6 Employees	Not Hiring	1	Menlo Park, California, United States
25	Leica Biosystems Biotechnology	1,852	Senior Field Service Engineer, Field Service Engineer II, Senior Manager, Quality Assurance (Deputy Management Representative)	>100	$100-500M		📊 Modest Growth: 0.54% 1,842 ↗ 1,852 Employees	⏸️ No Growth: 0% 17 Employees	Actively Hiring	17	Nußloch, Germany
26	ClinGen Resource Biotechnology	52	Baseline Annotation Volunteer at Clinical Genome Resource (ClinGen), Biocurator (Volunteer), Clinical Research Literature Annotation Volunteer	+29	$100-500M		⏸️ No Growth: 0% 52 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	23	Toronto, Canada
27	Integrated DNA Technologies Biotechnology	1,368	Laboratoriummedewerker, Process Engineer, Social Media and Content Marketing Manager	>100	$100-500M		📊 Modest Growth: 1.41% 1,349 ↗ 1,368 Employees	⏸️ No Growth: 0% 14 Employees	Actively Hiring	31	Coralville, Iowa, United States
28	Genopets Gaming	9	Co-Founder & CEO/CTO, Senior Full-Stack Engineer, Moderator in Discord	+10	$500-1,000M		⏸️ No Growth: 0% 9 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	9	Kerhonkson, New York, United States
29	Eugene Labs Genetics	20	Laboratory Technician, Operations and Customer Specialist, Founder & CEO	+28	$100-500M	$1M raised Series A, 10-01-2022	📊 Modest Growth: 5.26% 19 ↗ 20 Employees	⏸️ No Growth: 0% 3 Employees	Not Hiring	15	Melbourne, Australia
30	Mayo Clinic Laboratories Biotechnology	420	Technical Specialist, Laboratory Technologist, Clinical Pathologist	>100	$100-500M		📊 Modest Growth: 0.24% 419 ↗ 420 Employees	⏸️ No Growth: 0% 9 Employees	Not Hiring	29	Rochester, Minnesota, United States
31	CellCarta Biotechnology	563	Chief Medical & Scientific Officer, Project Manager, Vice President, Research and Development	>100	$100-500M		📊 Modest Growth: 0.18% 562 ↗ 563 Employees	⏸️ No Growth: 0% 7 Employees	Actively Hiring	16	Montreal, Canada
32	ABS Global Livestock	358	Procurement Manager, Senior Livestock Handler, REGIONAL SALES MANAGER	>100	$100-500M		📉 Negative Growth: -0.56% 360 ↘ 358 Employees	⏸️ No Growth: 0% 6 Employees	Not Hiring	26	DeForest, Wisconsin, United States
33	Sciex Biotechnology	1,812	Software Tester, Field Services Engineer, Field Service Aplication suport	>100	$100-500M		📊 Modest Growth: 0.67% 1,800 ↗ 1,812 Employees	⏸️ No Growth: 0% 10 Employees	Actively Hiring	17	Framingham, Massachusetts, United States
34	NeoGenomics Laboratories Biotechnology	1,160	Laboratory Technician, Director of Hematopathology, Histotechnologist	>100	$100-500M	$200M raised Post-IPO Equity, 05-05-2021	⏸️ No Growth: 0% 1,160 Employees	⏸️ No Growth: 0% 24 Employees	Actively Hiring	27	Fort Myers, Florida, United States
35	Denali Therapeutics Biotechnology	401	Manager Biomarker Operations, Senior Scientist, Associate Director of QA/QC	>100	$100-500M	$500M raised Post-IPO Equity, 02-27-2024	📊 Modest Growth: 2.56% 391 ↗ 401 Employees	⏸️ No Growth: 0% 18 Employees	Actively Hiring	19	San Francisco, California, United States
36	DNA Forensics Laboratory DNA Tests in India Genetics	7	Nurse, Founder, Chief Operating Officer	+6	$100-500M		⏸️ No Growth: 0% 7 Employees	⏸️ No Growth: 0% 2 Employees	Not Hiring	43	New Delhi, India
37	AGC Biologics Biotechnology	1,940	PPM system manager, Technician - Process Development, Sr. Scientist	>100	$100-500M		📊 Modest Growth: 0.67% 1,927 ↗ 1,940 Employees	⏸️ No Growth: 0% 17 Employees	Actively Hiring	33	Bothell, Washington, United States
38	Ultragenyx Biopharma	1,179	Facilities technician II, Director, Clinical QA and GxP Compliance, UltraCare Liaison	>100	$100-500M	$350M raised Post-IPO Equity, 06-13-2024	📊 Modest Growth: 2.43% 1,151 ↗ 1,179 Employees	⏸️ No Growth: 0% 58 Employees	Actively Hiring	27	Novato, California, United States
39	MedChemExpress Biotechnology	63	Sales And Marketing Specialist, Regional Sales Manager, Sales Manager	+79	$500-1,000M		📊 Modest Growth: 3.28% 61 ↗ 63 Employees	⏸️ No Growth: 0% 4 Employees	Actively Hiring	7	South Brunswick, New Jersey, United States
40	Caris Life Sciences Biotechnology	1,154	Head - Strategic Collaborations, Sales Director, Payroll Administrator	>100	$100-500M	$400M raised Debt Financing, 01-19-2023	📊 Modest Growth: 0.17% 1,152 ↗ 1,154 Employees	⏸️ No Growth: 0% 34 Employees	Actively Hiring	41	Irving, Texas, United States
41	Vitasoft Technologies Health Care	145	Software Engineer, Research Associate (Scientific writing), Customer Service Specialist	+13	$10-50M		📉 Negative Growth: -0.68% 146 ↘ 145 Employees	⏸️ No Growth: 0% 1 Employees	Actively Hiring	32	Chennai, India
42	Unilabs Health Care	188	Driftchef, Överläkare, Undersköterska	>100	$100-500M		📉 Negative Growth: -1.05% 190 ↘ 188 Employees	⏸️ No Growth: 0% 1 Employees	Actively Hiring	11	Solna, Sweden
43	Beam Therapeutics Biotechnology	464	Manager, QC Analytical, Senior Scientist, Research Associate	>100	$100-500M	$260M raised Post-IPO Equity, 01-19-2021	📊 Modest Growth: 1.98% 455 ↗ 464 Employees	⏸️ No Growth: 0% 25 Employees	Actively Hiring	18	Cambridge, Massachusetts, United States
44	GENETWORx Health Care	65	Director Of Laboratory Services, Medical Technologist, Medical Technician	>100	$100-500M		📉 Negative Growth: -2.99% 67 ↘ 65 Employees	⏸️ No Growth: 0% Employees	Not Hiring	34	Glen Allen, Virginia, United States
45	TruDiagnostic Health Care	37	HR Virtual Assistant, Product & Engineering Manager, VP of Operations	+34	$100-500M		📊 Modest Growth: 5.71% 35 ↗ 37 Employees	⏸️ No Growth: 0% 4 Employees	Actively Hiring	43	Lexington, Kentucky, United States
46	Wellcome Genome Campus Biotechnology	25	IT Director, Head of Engineering and Hard FM, Events Hospitality Team	+38	$500-1,000M		📉 Negative Growth: -3.85% 26 ↘ 25 Employees	⏸️ No Growth: 0% 3 Employees	Actively Hiring	16	South Cambridgeshire, United Kingdom
47	Molecular Devices Biotechnology	523	Sr. account executive, Account-Manager, Latin America Distribution Manager	>100	$100-500M		📊 Modest Growth: 0.38% 521 ↗ 523 Employees	⏸️ No Growth: 0% 8 Employees	Actively Hiring	11	San Jose, California, United States
48	Igbmc Biotechnology	273	Postdoctoral Researcher, Assistante administrative, PHD Student	>100	$100-500M		📊 Modest Growth: 1.87% 268 ↗ 273 Employees	⏸️ No Growth: 0% 1 Employees	Actively Hiring	9	Strasbourg, France
49	Bioted Biotechnology	1	Executive Director	+1	$100-500M		⏸️ No Growth: 0% 1 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	28	Badalona, Spain
50	Pathkind Labs Health Care	512	Deputy Manager Quality Assurance, Associate Director and Head of Haematology, FlowCytometry & Biochemistry, Supervisor	>100	$500-1,000M	$24M raised Private Equity Round, 05-20-2022	📉 Negative Growth: -3.94% 533 ↘ 512 Employees	⏸️ No Growth: 0% 13 Employees	Actively Hiring	24	Gurugram, India
51	Wellcome Trust Sanger Institute Biotechnology	1,019	Head of HR Business Partnering, Technical Specialist, Graduate Research Assistant	>100	$500-1,000M		📉 Negative Growth: -0.78% 1,027 ↘ 1,019 Employees	⏸️ No Growth: 0% 11 Employees	Actively Hiring	14	South Cambridgeshire, United Kingdom
52	Detect Lab Health Care	15	Public Relations, Technical Support, Customer Service	+47	$500-1,000M		⏸️ No Growth: 0% 15 Employees	⏸️ No Growth: 0% Employees	Not Hiring	14	Jamestown, New York, United States
53	InVivo Biosystems Bioinformatics	34	nemam, Optical Systems Engineer, nemam	+57	$100-500M	$2M raised Grant, 01-03-2024	📉 Negative Growth: -2.86% 35 ↘ 34 Employees	⏸️ No Growth: 0% 6 Employees	Not Hiring	30	Eugene, Oregon, United States
54	Healthy Holistic Living Health Care	3	Web Content Specialist, Freelance Writer	+2	$100-500M		⏸️ No Growth: 0% 3 Employees	⏸️ No Growth: 0% Employees	Not Hiring	40	Palm Harbor, Florida, United States
55	Cerba Biotechnology	194	Technicienne de laboratoire, Technicienne biologie moléculaire, Technicienne de laboratoire	>100	$100-500M		📉 Negative Growth: -3.96% 202 ↘ 194 Employees	⏸️ No Growth: 0% 1 Employees	Actively Hiring	7	Saint-Ouen-sur-Seine, France
56	Yourdnaportal Genetics	2	Specjalista ds. bioinformatyki, Director	+2	$100-500M		⏸️ No Growth: 0% 2 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	14	London, United Kingdom
57	AniCura Nederland Health Care	83	Veterinarian, Dierenarts, Paraveterinair	>100	$10-50M		⏸️ No Growth: 0% 83 Employees	⏸️ No Growth: 0% Employees	Actively Hiring	15	Amsterdam, Netherlands
58	Gentaur Genprice Group Biotechnology	7	Executive Assistant, accountant, Commerciale et support technique	+6	$100-500M		⏸️ No Growth: 0% 7 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	23	Kampenhout, Belgium
59	Bluebird bio Biotechnology	327	Director - National Accounts, Chief Executive Officer, External Manufacturing Operations Compliance Associate Manager	>100	$100-500M	$75M raised Post-IPO Debt, 03-18-2024	📉 Negative Growth: -6.3% 349 ↘ 327 Employees	⏸️ No Growth: 0% 34 Employees	Actively Hiring	10	Somerville, Massachusetts, United States
60	National Centre For Cell Science Nccs Health Care	51	Research Laboratory Technician, Research Student, Researcher	>100	$500-1,000M		⏸️ No Growth: 0% 51 Employees	⏸️ No Growth: 0% Employees	Not Hiring	20	Pune, India
61	NovoPro Bioscience Inc Biotechnology		Co-founder	+1	$500-1,000M		⏸️ No Growth: 0% Employees	⏸️ No Growth: 0% Employees	Not Hiring	5	Shanghai, China
62	Your DNA Guide Genetics	9	Educational Content Creator, Virtual Assistant, Owner	+7	$100-500M		⏸️ No Growth: 0% 9 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	36	Coral Springs, Florida, United States
63	Medendi Biotechnology	3	Amministratore delegato & Partner	+1	$100-500M		⏸️ No Growth: 0% 3 Employees	⏸️ No Growth: 0% 3 Employees	Not Hiring	22	Modena, Italy
64	Cefegen Biotechnology	2	Gerente y Directora Técnica, Tecnico Especialista en Laboratorio	+2	$100-500M		⏸️ No Growth: 0% 2 Employees	⏸️ No Growth: 0% Employees	Not Hiring	30	Madrid, Spain
65	DNA Express Genetics	1	Titolare	+1	$100-500M		⏸️ No Growth: 0% 1 Employees	⏸️ No Growth: 0% Employees	Not Hiring	33	Rome, Italy
66	Garvan Institute of Medical Research Biotechnology	484	Research Assistant, Research Officer, Clinical Research Coordinator - WA	>100	$100-500M		📊 Modest Growth: 0.21% 483 ↗ 484 Employees	⏸️ No Growth: 0% 15 Employees	Actively Hiring	36	Darlinghurst, Australia
67	International Society of Genetic Genealogy Genetics	2	Member	+1	$100-500M		⏸️ No Growth: 0% 2 Employees	⏸️ No Growth: 0% Employees	Not Hiring	19	Montvale, Virginia, United States
68	Ultima Genomics Bioinformatics	266	Sales Director, Genomic Applications, QA Manager, Field Service Engineer II	>100	$100-500M	$600M raised Venture Round, 05-31-2022	📊 Modest Growth: 3.5% 257 ↗ 266 Employees	⏸️ No Growth: 0% 8 Employees	Actively Hiring	6	Fremont, California, United States
69	BC Cancer Agency Biotechnology	25	IT Support Technician Co-op, Graduate Student, Client Support Technician Co-op	+25	$100-500M		📉 Negative Growth: -7.41% 27 ↘ 25 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	26	Vancouver, Canada
70	Wehi Health Care	770	Clinical Informatics Manager, PHD Student, Strategic Projects Development Manager	>100	$100-500M	$500k raised Grant, 01-01-2021	📉 Negative Growth: -0.65% 775 ↘ 770 Employees	⏸️ No Growth: 0% 7 Employees	Not Hiring	21	Melbourne, Australia
71	GeneDx Biotechnology	682	Scientist, Product Data Analyst, Lab Technician, Core	>100	$100-500M	$150M raised Post-IPO Equity, 01-27-2023	📊 Modest Growth: 1.79% 670 ↗ 682 Employees	⏸️ No Growth: 0% 20 Employees	Actively Hiring	29	Gaithersburg, Maryland, United States
72	Marrow Genetics	1	Faculty Member	+1	$100-500M		⏸️ No Growth: 0% 1 Employees	⏸️ No Growth: 0% Employees	Not Hiring	47	Bengaluru, India
73	Biovis Diagnostik MVZ Biotechnology	38	BTA, Laboratory Technician, Kaufmännischer Leiter	+40	$100-500M		📊 Modest Growth: 2.7% 37 ↗ 38 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	20	Limburg, Germany
74	AniCura AB Health Care	83	Head of Compliance, VP Operations, Chairman AniCura MIG Urology	>100	$100-500M		⏸️ No Growth: 0% 83 Employees	⏸️ No Growth: 0% Employees	Actively Hiring	7	Danderyd, Sweden
75	UniProt Biotechnology	5	User Experience Researcher, Scientific Database Curator, Senior Scientific Database Curator and Project Liaison	+5	$500-1,000M		⏸️ No Growth: 0% 5 Employees	⏸️ No Growth: 0% Employees	Not Hiring	11	Saffron Walden, United Kingdom
76	American Board of Genetic Counseling ABGC Genetics	5	American Board of Genetic Counseling DEIJ Committee, ABGC Nominating Committee Chair	+2	$100-500M		⏸️ No Growth: 0% 5 Employees	⏸️ No Growth: 0% 4 Employees	Not Hiring	19	Chicago, Illinois, United States
77	Miltenyi Biotec Biotechnology	2,155	Group Leader Material & Production Planning, Account manager Research, Molecular Technology Intern	>100	$500-1,000M		📊 Modest Growth: 0.23% 2,150 ↗ 2,155 Employees	⏸️ No Growth: 0% 20 Employees	Actively Hiring	4	Bergisch Gladbach, Germany
78	pharmtech.com Biopharma	1	DST INSPIRE SENIOR RESEARCH FELLOW, Pharmacist, Pharmacist	+8	$100-500M		⏸️ No Growth: 0% 1 Employees	⏸️ No Growth: 0% Employees	Not Hiring	33	Woodbridge Township, New Jersey, United States
79	Inside Precision Medicine Biotechnology	8	Asistente directivo de Marketing, Editor In Chief, Editor	+9	$100-500M		⏸️ No Growth: 0% 8 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	37	City of New Rochelle, New York, United States
80	John Innes Centre Agriculture	277	Catering Assistant, PhD Student, Postdoctoral Researcher	>100	$100-500M		⏸️ No Growth: 0% 277 Employees	⏸️ No Growth: 0% 2 Employees	Not Hiring	13	Norwich, United Kingdom
81	LGC, Biosearch Technologies Biotechnology	362	Commercial Director APAC, Import-Export Manager, Sales Manager Iberia	>100	$100-500M		📉 Negative Growth: -0.82% 365 ↘ 362 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	16	Hoddesdon, United Kingdom
82	Takara Bio USA Biotechnology	174	Account Manager - France North-East & Paris surroundings, Territory Manager, Senior Corporate Counsel	>100	$500-1,000M		📊 Modest Growth: 1.75% 171 ↗ 174 Employees	⏸️ No Growth: 0% 3 Employees	Actively Hiring	10	San Jose, California, United States
83	Novogene Biotechnology	85	Account Manager, Technical Support, Account Manager	>100	$100-500M		⏸️ No Growth: 0% 85 Employees	⏸️ No Growth: 0% 8 Employees	Not Hiring	23	Yuexiu District, China
84	Institute of Molecular Biology Biotechnology	139	Doctoral Student, PhD student, Assistant Project Coordinator	>100	$100-500M		📉 Negative Growth: -0.71% 140 ↘ 139 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	9	Mainz, Germany
85	Livestock Improvem Agriculture	629	lic, risk maneger, consultant	>100	$500-1,000M		📉 Negative Growth: -1.26% 637 ↘ 629 Employees	⏸️ No Growth: 0% 19 Employees	Actively Hiring	25	Newstead, New Zealand
86	Aldevron Biopharma	644	Technical Writer, Operational Quality Assurance Supervisor, Biomanufacturing Operator	>100	$100-500M		📉 Negative Growth: -0.62% 648 ↘ 644 Employees	⏸️ No Growth: 0% 9 Employees	Actively Hiring	3	Fargo, North Dakota, United States
87	Victorian Clinical Genetics Services VCGS Genetics	142	Customer Care Operator, Clinical Genetics Fellow, Deputy Head Biochemical Genetics	>100	$100-500M		📉 Negative Growth: -0.7% 143 ↘ 142 Employees	⏸️ No Growth: 0% 6 Employees	Not Hiring	18	Melbourne, Australia
88	SOPHiA GENETICS Biotechnology	420	Software Development Engineer II, Head of Talent Management, Business Analyst	>100	$100-500M	$15M raised Post-IPO Debt, 05-02-2024	📊 Modest Growth: 1.94% 412 ↗ 420 Employees	⏸️ No Growth: 0% 14 Employees	Actively Hiring	47	Rolle, Switzerland
89	Dermpath Diagnostics Health Care	85	Data Entry Operator, Dermatology Account Executive, Dermatopathologist	>100	$500-1,000M		⏸️ No Growth: 0% 85 Employees	⏸️ No Growth: 0% Employees	Not Hiring	17	Port Chester, United States
90	BioFire Diagnostics Biotechnology	487	Master Data Analyst, Postmarket Surveilance, QC Technologist	>100	$100-500M	$45M raised Venture Round, 05-02-2013	📉 Negative Growth: -1.22% 493 ↘ 487 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	24	Salt Lake City, Utah, United States
91	R&D Systems Biotechnology	153	System Administrator, Project Manager, Test Development Engineer	>100	$500-1,000M		⏸️ No Growth: 0% 153 Employees	⏸️ No Growth: 0% Employees	Not Hiring	22	Abingdon, United Kingdom
92	IDEXX Water Testing Australia AND New Zealand Health Care	1	Water Account Manager New Zealand, Key Account Manager , Australia	+2	$100-500M		⏸️ No Growth: 0% 1 Employees	⏸️ No Growth: 0% Employees	Not Hiring	19	Sydney, Australia
93	MyDNA Health Care	20	Full Stack Developer, Consultant Pharmacist, QA Analyst	+23	$100-500M	$7M raised Series A, 12-02-2016	📊 Modest Growth: 5.26% 19 ↗ 20 Employees	⏸️ No Growth: 0% 5 Employees	Not Hiring	38	Melbourne, Australia
94	Enzo Life Sciences Biotechnology	101	lab tech, Accounts Receivable Analyst, Admin. Associate	>100	$100-500M	$15M raised Post-IPO Equity, 02-05-2007	📉 Negative Growth: -3.81% 105 ↘ 101 Employees	⏸️ No Growth: 0% 1 Employees	Not Hiring	19	Farmingdale, New York, United States
95	Slavov Lab Biotechnology	4	PhD Candidate, Student Research Assistant, Postdoctoral Researcher	+4	$100-500M		⏸️ No Growth: 0% 4 Employees	⏸️ No Growth: 0% Employees	Not Hiring	21	Boston, Massachusetts, United States
96	BioWorld Biotechnology	2	Financial Manager, Products Specialist, Senior Field Service Engineer	+5	$100-500M		⏸️ No Growth: 0% 2 Employees	⏸️ No Growth: 0% Employees	Not Hiring	12	Atlanta, Georgia, United States
97	Human Cell Atlas Health Care	6	Events and Administrative Coordinator (Asia), Member, Member, Data Processing and Lab Automation	+5	$500-1,000M		⏸️ No Growth: 0% 6 Employees	⏸️ No Growth: 0% Employees	Not Hiring	28	Manchester, United Kingdom
98	Recursion Biotechnology	678	Research Associate II, Infrastructure Engineer, Research Associate	>100	$100-500M	$200M raised Post-IPO Equity, 06-26-2024	📊 Modest Growth: 0.44% 675 ↗ 678 Employees	⏸️ No Growth: 0% 22 Employees	Actively Hiring	18	New York, United States
99	NanoString Technologies Biotechnology	264	Information Systems Engineering Director, Lead Research Associate, Project & Service Sales Representative \| France & Switzerland	>100	$100-500M	$47M raised Post-IPO Debt, 02-05-2024	📉 Negative Growth: -1.49% 268 ↘ 264 Employees	⏸️ No Growth: 0% 5 Employees	Not Hiring	27	Seattle, Washington, United States
100	Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures Biotechnology	42	Head of Bioinformatics and IT, Senior Scientist, Bioinformatiker	+86	$500-1,000M		⏸️ No Growth: 0% 42 Employees	⏸️ No Growth: 0% Employees	Actively Hiring	17	Braunschweig, Germany

249

100

Market Expansion

Top Financial Services Companies in Germany

14 October 2025

By Surfe

207

100

Market Expansion

Top Pharmaceutical Companies in Spain

14 October 2025

By Surfe

201

Market Expansion

Top Energy Companies in Germany

14 October 2025

By Surfe

195

Growth

Top SaaS Companies in Germany

14 October 2025

By Surfe

178

100

Market Expansion

Top Farming Companies in Canada

26 September 2025

By Surfe

173

Intelligent Prospecting, Backed by Signals

In selling to the genetics industry, how critical is demonstrating ROI early in the sales process?

Budgets in genetics move only when a clear payback is on the table. Capital is tight, validation is expensive, and every new tool competes with headcount and consumables. If a buyer cannot show finance how your solution lowers cost per sample, speeds turnaround, or increases throughput this quarter, your deal will stall behind the next grant cycle. Treat ROI like your entry ticket, not a closing argument. Like a clinical trial, your deal needs endpoints. Lead with a spreadsheet, not a slide.

Give buyers numbers they can defend. Anchor on three levers they already track: samples per week per instrument, hands-on minutes per run, and rerun or failure rates. Then translate each into dollars. For example: “If we lift throughput 12 percent on your two busiest lines and cut reruns by 15 percent, your cost per sample drops about 8 percent. That funds the rollout in under six months.” Keep it simple, conservative, and tied to their data. Offer a tight pilot plan: one site, four weeks, success criteria set with the lab lead and finance. Bring a one-page ROI calculator that uses their inputs and shows payback by month. Ask questions that surface impact: Where are delays costing you revenue today, in sample prep or data review? What is the current cost when a run fails and needs a repeat? If we return results 24 to 48 hours faster, how many more samples can you accept without adding headcount?

Two lines to keep handy: No ROI, no PO. If it cannot hit a milestone this quarter, it will not clear a committee next quarter.

How can B2B salespeople leverage industry trends to resonate more deeply with prospects in the genetics field?

The fastest way to win a genetics deal is to speak to their next milestone, not your next feature. Genetics teams live in sprints. One quarter it is pushing a new assay to validation. The next it is proving clinical utility for payers. Tie your outreach to the waves they are already surfing. Cost per genome keeps falling, throughput is rising, and regulators are watching. That creates a simple business tension. Scale without delays, or watch margin and credibility evaporate. Use that tension in your opener. Try this: Many teams are doubling samples but not headcount. Where does your process bend first, turnaround time or data QC?

Turn trends into talk tracks. If they are moving research tools into clinical use, lead with risk and revenue. When results slip by 24 hours, what happens to revenue recognition and provider satisfaction that week. If AI is touching their analysis, keep it practical. Where are analysts still copying data between tools, and what does that manual hour cost you per sample. If they sell into hospitals, bring reimbursement to the front. Which evidence gaps are blocking coverage today, and how are you capturing outcomes to close them. For population genomics or biobank partnerships, press on collaboration friction. How fast can a new partner access the right data with the right consent. What is the current calendar lag from signature to first data pull. If they run labs, link supply and margin. When reagent backorders hit, do you protect priority accounts or throughput. What did that decision cost last quarter.

Two lines to keep handy. Lead with the trend, land on the business impact. Speed wins when accuracy is assumed. Use them to frame a short, specific ask tied to their quarter. That is how you sound like a partner who gets genetics, not another vendor fishing for a demo.

What unique pain points do genetics companies experience that a tailored sales approach could alleviate?

Genetics runs on two clocks: the science moves fast, approvals move slow. That lag is where money leaks. Lab teams wrestle with validation and compliance that never end, while commercial teams promise turnaround times that ops cannot consistently hit. Add cold chain logistics and consent management, and a single missed step can mean a re-collection, a delayed report, and a frustrated clinician. Buying is complex too. You are not selling to one champion. You are selling to a committee that includes a lab director, compliance, security, procurement, and sometimes a principal investigator. The result is long cycles, conservative decisions, and high bars for proof. The cost is real: slower launches, lower sample throughput, unpredictable margins, and brand risk if privacy or chain of custody looks shaky. In this world, price is rarely the blocker. Perceived risk is.

A tailored approach succeeds when you lead with certainty, not features. Anchor on outcomes they care about: predictable turnaround, clean audit trails, fewer re-runs, and smoother signoffs. Use lines they can repeat to their CFO and QA. Try these questions to open doors and de-risk the deal: Where do delays most often occur, sample intake or report signoff. How do you prevent re-collections and what does a failed sample cost your team. Which regulatory framework is the hard gate right now, CLIA, CAP, IVDR, or payer documentation. When interpretations change, how do you manage reanalysis and outreach without crushing your team. What evidence does procurement need to greenlight a pilot in under 30 days. Who owns data privacy and what would make them say yes on the first pass. Bring proof that shortens the path to yes: clear validation artifacts, security answers up front, references from similar audited labs, and a simple pilot plan tied to a measurable metric like turnaround time reduction or fewer sample exceptions. Memorable lines to keep handy: Compliance is not a feature. It is the ticket in. Speed that creates doubt is not speed. It is rework.

How do decision-makers in top genetics companies evaluate potential tech solutions?

They buy with evidence, not adjectives. In this sector, speed only counts if it survives an audit. Decision-makers stack rank solutions by three things: proof, compliance, and fit. Proof means real results on real datasets, not slideware. Compliance means being ready for HIPAA, GDPR, CLIA, CAP, and clean audit trails. Fit means it plugs into their world without drama. That world includes LIMS and ELN, data pipelines, strict access controls, and a budget that crosses R&D, clinical, IT, and QA. They ask for a pilot that shows faster turnaround time, fewer reruns, stable uptime, and clear cost per sample improvements. They look for references from similar assays or programs. They want to see a validation plan, not just a demo. If it cannot pass Security and QA, it will never see production.

Map the buy circle early. You will meet a scientific lead, a lab operations owner, a data or IT security gatekeeper, a QA or regulatory voice, and finance. The process is predictable. A quick technical review. A security questionnaire. A pilot on a narrow workflow. A validation checklist. Then a cross-functional go or no-go. Your job is to help them de-risk each step. Bring a pilot plan, a compliance packet, and a clear integration path. Translate features into outcomes they can defend to an auditor and a CFO.

Try questions like:
- When volume doubles, where does your current process break first: turnaround time, cost per sample, or audit readiness?
- What would shaving 7 days off your validation timeline unlock for revenue or submissions?
- Which team is the hardest blocker today: Security, QA, or Finance, and why?
- Do you have a target for rerun reduction or report delivery time this quarter?
- What systems must this plug into on day one to avoid extra headcount?

Two lines to keep handy: Proof beats promise. Fast is good, compliant and repeatable is bought.

What role does compliance and data security play when genetics companies make purchasing decisions?

In this market, compliance is the bouncer at the door and data security is the only ID that gets you in. Genetics companies do not treat it as a checkbox. It is how they protect patient genomes, clinical outcomes, and their IP. If a vendor increases regulatory risk, the deal stalls or dies. That has real cost. Slipped trial timelines. Lost partnerships with hospitals and pharma. Damaged brand with patients who gave consent in good faith. Think of it like a lab chain of custody for software. Every control, audit log, and approval keeps data clean, provable, and defensible. Trust is the currency of genomics. No trust, no trial, no sale.

For prospecting, lead with risk reduction and speed to greenlight. Show that you understand the review sequence: Vendor Risk Management, Privacy, InfoSec, QA, then Procurement. Offer a clean security packet upfront. SOC 2 or ISO 27001, recent pen test summary, data flow diagram, access controls, encryption in transit and at rest, retention and deletion policies, incident response, and a DPA with clear subprocessor lists. If they handle PHI, be ready to discuss a BAA. If they operate in the EU, address data residency and cross border transfers. If they run regulated studies, be prepared to speak to validation, audit trails, and electronic records requirements. The win is simple. Shorter reviews, fewer surprises, faster revenue. Treat compliance like a feature, not fine print.

Use these discovery questions to unlock momentum:
- Which frameworks govern this purchase, for example HIPAA, GDPR, Part 11, GxP?
- What data types will flow through the tool, PHI, genomic, or proprietary IP?
- Do you require data residency in the EU or specific regions?
- What evidence do you need from vendors to pass InfoSec on the first try?
- Who signs off beyond IT, Privacy, QA, Clinical, Legal?
- What would cut two weeks from your security review?

What communication strategies have proven most effective when engaging with senior leaders at genetics firms?

The shortcut to a senior genetics leader’s inbox is to speak in milestones, not features. Their week is measured in IND timelines, assay validation, CLIA readiness, trial enrollment, and launch windows. Lead with what you can de-risk in the next 90 days. If you can tie your message to fewer reruns, faster QC, clearer evidence for payers, or a cleaner audit trail, you earn attention. Miss that and you sound like another tool in search of a problem. One slip can burn millions and kill a conference moment. Your copy should feel like an insurance policy on a milestone they must hit. Sticky line to remember: Talk in milestones, not features.

Tactics that work with companies on the Top Genetics Companies list: personalize using public signals. Reference their pipeline page, latest conference abstract, or trial registry update, then connect your value to a specific phase gate. Keep the opener under three lines. Example: “Saw your cell therapy expansion and the CLIA timeline you mentioned at ASHG. Teams like X cut rework by 18 percent by standardizing sample intake and QC. Open to a 15-minute review of what would move your timeline forward this quarter?” Anchor to one metric tied to cost or time. Offer a small pilot with clear success criteria, timeline, and an exit plan. Name compliance in one sentence so they do not need to ask. Use peer credibility from adjacent modalities, not generic logos. Avoid hype. Precision beats adjectives.

Conversation starters that land:
- Which milestone is most at risk this quarter: assay validation, IND-enabling studies, or enrollment ramp?
- Where do you see the most rework today: sample intake, contamination, or data QC?
- What is your current cycle time from sample receipt to a go or no-go decision, and what would a 10 to 15 percent reduction unlock?
- How are you preparing for your next data readout or conference, and what must be true to hit that date with confidence?
- If we ran a 30-day pilot, what success metric would get your COO or CSO to greenlight scale?

Keep the package tight: a 3-sentence email, a 90-second overview, and a one-page brief with metrics and a pilot path. Follow their calendar, not yours. Hit before investor calls and key meetings, then step back. Final line to jot down: If it does not de-risk the next quarter, it does not matter.